Efficacy and Long-term Peripheral Sensory Neuropathy of 3 vs 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Long-term Peripheral Sensory Neuropathy of 3 vs 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer

Published:2019-11-01 Issue:11 Volume:5 Page:1574
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Yoshino Takayuki¹,Yamanaka Takeharu²,Oki Eiji³,Kotaka Masahito⁴,Manaka Dai⁵,Eto Tetsuya⁶,Hasegawa Junichi⁷,Takagane Akinori⁸,Nakamura Masato⁹,Kato Takeshi¹⁰,Munemoto Yoshinori¹¹,Takeuchi Shintaro¹²,Bando Hiroyuki¹³,Taniguchi Hiroki¹⁴,Gamoh Makio¹⁵,Shiozawa Manabu¹⁶,Mizushima Tsunekazu¹⁷,Saji Shigetoyo¹⁸,Maehara Yoshihiko¹⁸,Ohtsu Atsushi¹,Mori Masaki³

Affiliation:

1. National Cancer Center Hospital East, Chiba, Japan

2. Yokohama City University School of Medicine, Kanagawa, Japan

3. Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan

4. Sano Hospital, Hyogo, Japan

5. Kyoto Katsura Hospital, Kyoto, Japan

6. Tsuchiura Kyodo General Hospital, Ibaraki, Japan

7. Osaka Rosai Hospital, Osaka, Japan

8. Hakodate Goryoukaku Hospital, Hokkaido, Japan

9. Aizawa Hospital, Nagano, Japan

10. Kansai Rosai Hospital, Hyogo, Japan

11. Fukui-ken Saiseikai Hospital, Fukui, Japan

12. Teine Keijinkai Hospital, Hokkaido, Japan

13. Ishikawa Prefectural Central Hospital, Ishikawa, Japan

14. Kyoto Second Red Cross Hospital, Kyoto, Japan

15. Osaki Citizen Hospital, Miyagi, Japan

16. Kanagawa Cancer Center, Kanagawa, Japan

17. Osaka University Graduate School of Medicine, Osaka, Japan

18. Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, Japan

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2749687/jamaoncology_yoshino_2019_oi_190059.pdf

Reference26 articles.

1. Early colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.;Labianca;Ann Oncol,2013

2. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer.;Watanabe;Int J Clin Oncol,2018

3. Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen.;André;J Clin Oncol,1999

4. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.;de Gramont;J Clin Oncol,2000

5. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer.;Giacchetti;J Clin Oncol,2000

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 months;European Journal of Cancer;2024-09

2. QUATTRO-II randomized trial: CAPOXIRI+bevacizumab vs. FOLFOXIRI+bevacizumab as first-line treatment in patients with mCRC;Med;2024-09

3. Peripheral Neuropathy in Cancer Patients- Multifactorial Contributors to Dose Limiting and Chronic Toxicity;2024-07-26

4. Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR);Digestive and Liver Disease;2024-05

5. Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer;Journal of Clinical Oncology;2024-05-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3